"For more than 70 years, Cincinnati Eye Institute's eye care center has been serving the community with first class eye care. We treat more complex and more routine conditions than any other facility or hospital. As an ophthalmology clinic, we also have an Urgent Eye Clinic for emergency care. Cincinnati Eye Institute’s internationally recognized doctors are rated in the top 1%. The CEI team treats more complex and more routine conditions than any other facility or hospital. To learn more about your doctor or search by specialty, use the alphabetical listing and tools on this page."

During the past decade, Cincinnati Eye Institute conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 9 clinical trials were completed, i.e. on average, 40.9% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 8 clinical trials were completed. i.e. 72.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cincinnati Eye Institute" #1 sponsor was "Mati Therapeutics Inc." with 3 trials, followed by "Bausch & Lomb Incorporated" with 2 trials sponsored, "Noveome Biotherapeutics, formerly Stemnion" with 2 trials sponsored, "Sight Sciences, Inc." with 2 trials sponsored and "Surface Ophthalmics, Inc." with 2 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cincinnati Eye Institute" #1 collaborator was "Alcon Research" with 2 trials as a collaborator, "Bausch & Lomb Incorporated" with 1 trials as a collaborator, "ClinReg Consulting Services, Inc." with 1 trials as a collaborator, "IQVIA Biotech" with 1 trials as a collaborator and "National Eye Institute (NEI)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Cincinnati Eye Institute" are "Cataract" (3 trials), "Dry Eye Disease" (3 trials), "Dry Eye Syndromes" (3 trials), "Corneal Edema" (2 trials) and "Keratoconjunctivitis Sicca" (2 trials). Many other conditions were trialed in "Cincinnati Eye Institute" in a lesser frequency.

Most popular intervention types in "Cincinnati Eye Institute" are "Drug" (18 trials), "Device" (6 trials), "Biological" (3 trials), "Other" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Restasis" (2 trials), "ST266" (2 trials), "Vehicle" (2 trials) and "0.02% Betamethasone Sodium Phosphate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cincinnati Eye Institute" are 27 trials for "All" genders.

Currently, there are NaN active trials in "Cincinnati Eye Institute". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Cincinnati Eye Institute, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Cincinnati Eye Institute, 3 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 6 trials that are defined as “Not Applicable".